Pathology Industry in Japan Market Research & Statistics

24/7 Customer Support

Talk to Sam

+1 718 473 0872

All regions

About 300 reports

Download Unlimited Documents from Trusted Public Sources

Pathology Description in Japan

  • September 2014
    6 pages
  • Pathology  

  • Japan  

View report >

Pathology Description in Japan

  • September 2014
    7 pages
  • Cancer  

  • Japan  

View report >

Pathology Description in Japan

  • September 2014
    6 pages
  • Cancer  

  • Japan  

View report >

Pathology Description in Japan

  • September 2014
    6 pages
  • Stroke  

  • Japan  

View report >

Pathology Description in Japan

  • September 2014
    9 pages
  • Pathology  

  • Japan  

View report >

Pathology Description in Japan

  • September 2014
    6 pages
  • Stroke  

  • Japan  

View report >

Pathology Description in Japan

  • September 2014
    6 pages
  • Stroke  

  • Japan  

View report >

Pathology Description in Japan

  • September 2014
    9 pages
  • Stroke  

  • Japan  

View report >

Pathology Description in Japan

  • September 2014
    9 pages
  • Glucose  

  • Japan  

View report >

Pathology Description in Japan

  • September 2014
    8 pages
  • Stroke  

  • Japan  

View report >

Search in Pathology Industry

About 400 reports

Purchase Reports From Reputable Market Research Publishers
(From $ 250 - $ 4 995)

PharmaPoint: HER2-Positive Breast Cancer - Japan Drug Forecast and Market Analysis to 2023

PharmaPoint: HER2-Positive Breast Cancer - Japan Drug Forecast and Market Analysis to 2023

  • $ 4 995
  • Industry report
  • September 2014
  • by Global Data

PharmaPoint: HER2-Positive Breast Cancer - Japan Drug Forecast and Market Analysis to 2023 Summary HER2-positive breast cancer is the second most common cancer in the world and the most common cancer in ...

Epicast Report: Colorectal Cancer - Epidemiology Foreca ...

December 2014 $ 3 995

Epicast Report: Rheumatoid Arthritis - Epidemiology For ...

December 2014 $ 3 995

Epicast Report: Type 1 Diabetes - Epidemiology Forecast ...

November 2014 $ 3 995

Epicast Report: Irritable Bowel Syndrome - Epidemiology ...

October 2014 $ 3 995

Epicast Report: Dyslipidemia - Epidemiology Forecast To ...

October 2014 $ 3 995

Herceptin (her2-positive Breast Cancer) - Forecast And ...

September 2014 $ 3 495

Perjeta (her2-positive Breast Cancer) - Forecast And Ma ...

September 2014 $ 3 495

Kadcyla (her2-positive Breast Cancer) - Forecast And Ma ...

September 2014 $ 3 495

Tykerb (her2-positive Breast Cancer) - Forecast And Mar ...

September 2014 $ 3 495


ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.